Therapeutic effect of withania somnifera on pristane-induced model of SLE

Inflammopharmacology

Volumn 20, Issue 4, 2012, Pages 195-205

  Minhas, Ujla ^a   Minz, Ranjana ^b   Das, Prabir ^b   Bhatnagar, Archana ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Autoantibodies; Immune complexes; Immunomodulatory properties; Inflammation; Pristane induced model of SLE; Withania somnifera

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE; PRISTANE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; WITHANIA SOMNIFERA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNE COMPLEX DEPOSITION; INFLAMMATION; LIPOGRANULOMA; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; POWDER; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84864927212     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0102-8     Document Type: Article

References (37)

1. Aalinkeel R, Hu Z, Nair BB, Sykes DE, Reynolds JL, Mahajan SD et al (2010) Genomic analysis highlights the role of the JAKSTAT signaling in the anti-proliferative effects of dietary flavonoid-'Ashwagandha' in prostate cancer cells. Evid Based Complement Altern Med 7:177-187
2. Amara S, Kumar SP, Athota RR (1999) Effect Of Withania somnifera root extract on the induction of anti-ovalbumin IgE antibody response in mice. Pharm Biol 37:253-259 (Pubitemid 30035137)
3. Bhatnagar M, Sharma D, Salvi M (2009) Neuroprotective effects of Withania somnifera dunal.: A possible mechanism. Neurochem Res 34:1975-1983
4. Burns JJ, Zhao L, Taylor EW, Spelman K (2010) The influence of traditional herbal formulas on cytokine activity. Toxicology 278:140-159
5. Calero I, Sanz I (2010) Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Discov Med 10:416-424
6. Calvani N, Caricchio R, Tucci M, Sobel ES, Silvestris F, Tartaglia P et al (2005) Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J Immunol 175:4777-4782 (Pubitemid 41362020)
7. Chatterjee S, Srivastava S, Khalid A, Singh N, Sangwan RS, Sidhu OP et al (2010) Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. Phytochemistry 71:1085-1094
8. Chopra A, Lavin P, Patwardhan B, Chitre D (2004) A 32 week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 10:236-245 (Pubitemid 39332161)
9. Christina AJ, Joseph DG, Packialakshmi M, Kothai R, Robert SJ, Chidambaranathan N et al (2004) Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma. J Ethnopharmacol 93:359-361 (Pubitemid 38962429)
10. Davis L, Kuttan G (1999) Effect of Withania somnifera on cytokine production in normal and cyclophosphamide treated mice. Immunopharmacol Immunotoxicol 21:695-703
11. Dedera DA, Urashima M, Chauhan D, LeBrun DP, Bronson RT, Anderson KC (1996) Interleukin-6 is required for pristaneinduced plasma cell hyperplasia in mice. Brit J Haematol 94:53-61 (Pubitemid 26232539)
12. Dhuley JN (1997) Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice. J Ethnopharmacol 58:15-20 (Pubitemid 27406182)
13. Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M (1999) Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 26:318-324 (Pubitemid 29066735)
14. Griffiths HR (2008) Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev 7:544-549
15. Hayashi T (2010) Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-c targeting gene therapy. J Biomed Biotechnol 2010:19. doi:10.1155/2010/ 461641
16. Kielland A, Blom T, Nandakumar KS, Holmdahl R, Blomhoff R, Carlsen H (2009) In vivo imaging of reactive oxygen and nitrogen species in inflammation using the luminescent probe L-012. Free Radic Biol Med 47:760-766
17. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33:91-95
18. Lattanzio G, Libert C, Aquilina M, Cappelletti M, Ciliberto G, Musiani P et al (1997) Defective development of pristane-oilinduced plasmacytomas in interleukin-6-deficient BALB/c mice. Am J Pathol 151:689-696 (Pubitemid 27385600)
19. Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA et al (2007a) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12:2115-2133 (Pubitemid 47498235)
20. Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN (2007b) A standardized root extract of Withania somnifera and its major constituent withanolide- A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci 80:1525-1538 (Pubitemid 46399749)
21. Mishra LC, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev 5:334-346 (Pubitemid 30660827)
22. Nikolova KA, Mihaylova NM, Voynova EN, Tchorbanov AI, Voll RE, Vassilev TL (2010) Selective silencing of autoreactive B lymphocytes-following the nature's way. Autoimmun Rev 9:775-779
23. Rasool M, Varalakshmi P (2006) Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: an in vivo&in vitro study. Vascul Pharmacol 44:406-410 (Pubitemid 43766670)
24. Reeves WH, Lee PY, Weinstein JS, Minoru Satoh, Lu L (2009) Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 30:455-464
25. Rose NR, Friedman H, Fahey JL (1986) Manual of clinical laboratory immunology 3rd ed. American society for microbiology 1913 Ist N.W. Washington DC, 20006
26. Samy RP, Pushparaj PN, Gopalakrishnakone P (2008) A compilation of bioactive compounds from Ayurveda. Bioinformation 3:100-110
27. Sarkar M, Varshney R, Chopra M, Sekhri T, Adhikari JS (2005) Flow-cytometric analysis of ROS in PBMC of patients with thyroid disfunction. Cytom B Clin Cytom 70:20-23
28. Satoh M, Reeves WH (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 180:2341-2346 (Pubitemid 24351616)
29. Satoh M, Kumar A, Kanwar YS, Reeves WH (1995) Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci USA 92:10934-10938
30. Satoh M, Kuroda Y, Yoshida H, Behney KM, Mizutani A, Akaogi J et al (2003) Induction of lupus-related autoantibodies by adjuvants. J Autoimmun 21:1-9
31. Shah NS, Billiar TR (1998) Role of nitric oxide in Inflammation and tissue injury during endotoxemia and hemorrhagic shock. Environ Health Perspect 106:1139-1143 (Pubitemid 28554518)
32. Shukla KK, Mahdi AA, Mishra V, Rajender S, Sankhwar SN, Patel D, Das M (2011) Withania somnifera improves semen quality by combating oxidative stress and cell death and improving essential metal concentrations. Reprod Biomed Online. (Epub ahead of print)
33. Smolen JS, Steiner G, Aringer M (2005) Anti-cytokine therapy in systemic lupus erythematosus. Lupus 14:189-191 (Pubitemid 40445581)
34. Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M (2006) Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 11:128-150 (Pubitemid 44050251)
35. Uppal SS, Hayat SJ, Raghupathy R (2009) Efficacy and safety of infliximab in active SLE: a pilot study. Lupus 18:690-697
36. Wanchu A, Khullar M, Deodhar SD, Bambery P, Sud A (1998) Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 18:41-43 (Pubitemid 28432832)
37. Yamamoto K, Akbar SM, Masumoto T, Onji M (1998) Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC). Clin Exp Immunol 114:94-101 (Pubitemid 28442819)